Trends in Modes of Death in Heart Failure Over the Last Two Decades: Less Sudden Death but Cancer Deaths on the Rise
Open Access
- 30 July 2019
- journal article
- research article
- Published by Oxford University Press (OUP) in European Journal of Heart Failure
- Vol. 21 (10) , 1259-1266
Abstract
Aims Better management of heart failure (HF) over the past two decades has improved survival, mainly by reducing the incidence of death due to cardiovascular (CV) causes. Deaths due to non‐CV causes, particularly cancer, may be increasing. This study explored the modes of death of consecutive patients who attended a HF clinic over 17 years. Methods and results A total of 935 deaths were ascertained from 2002 to 2018 among 1876 patients (mean age 65.8 ± 12.5 years, 75% men, left ventricular ejection fraction < 50%) admitted to our HF clinic. Median follow‐up was 4.2 years [1.9–7.8]. Mode of death was curated from patient health records and verified by the Catalan and Spanish health system databases. Trends for every mode of death were assessed by polynomial regression. Two trends were observed: a significant reduction in sudden death (P = 0.03) without changes in HF progression as mode of death (P = 0.26), and a significant increase in non‐CV modes of death (P < 0.001). Non‐CV deaths accounted for 17.4% of deaths in 2002 and 65.8% of deaths in 2018. A total 138 deaths were due to cancer (37% of non‐CV deaths). A significant trend was observed towards a progressive increase in cancer deaths over time (P = 0.002). The main mode of cancer mortality was lung cancer. Conclusions The modes of death in HF have shifted over the last two decades. Patients with HF die less due to sudden death and more due to non‐CV causes, mainly cancer. Whether HF triggers cancer, or cancer develops in HF survivors, deserves further insight.Keywords
This publication has 28 references indexed in Scilit:
- Angiotensin–Neprilysin Inhibition versus Enalapril in Heart FailureNew England Journal of Medicine, 2014
- ESC Guidelines for the diagnosis and treatment of acute and chronic heart failure 2012: The Task Force for the Diagnosis and Treatment of Acute and Chronic Heart Failure 2012 of the European Society of Cardiology. Developed in collaboration with the Heart Failure Association (HFA) of the ESCEuropean Heart Journal, 2012
- Estimated Glomerular Filtration Rate and Prognosis in Heart FailureJACC, 2012
- Mortality rates and modes of death in heart failure patients with reduced versus preserved systolic functionEuropean Journal of Internal Medicine, 2011
- Mode of Death in Patients with Newly Diagnosed Heart Failure in the General PopulationEuropean Journal of Heart Failure, 2008
- ESC Guidelines for the Diagnosis and Treatment of Acute and Chronic Heart Failure 2008European Journal of Heart Failure, 2008
- Innate Immune Activation Through Nalp3 Inflammasome Sensing of Asbestos and SilicaScience, 2008
- Clinical epidemiology of heart failureHeart, 2007
- Guidelines for the diagnosis and treatment of chronic heart failure: executive summary (update 2005)European Heart Journal, 2005
- Guidelines for the diagnosis and treatment of chronic heart failureEuropean Heart Journal, 2001